Import license medical devices India, CDSCO Form MD-14, MD-15 import license, SUGAM portal medical devices, and CDSCO medical device import 2026 are essential for global manufacturers targeting India’s booming $15B+ medtech market. With full enforcement across all risk classes since late 2023 and perpetual validity for approved licenses, mastering the Form MD-14 process in 2026 is key to seamless entry and avoiding customs delays.
India’s medical device import regime, governed by the Medical Devices Rules, 2017 (with ongoing amendments), requires an import license in Form MD-15 issued by the Central Drugs Standard Control Organization (CDSCO) for most devices. Foreign manufacturers cannot apply directly—they must appoint an Authorized Indian Agent (AIA) with a valid wholesale or manufacturing license (e.g., Form 20/21B or MD-42). The AIA submits the application via Form MD-14 on the SUGAM portal, CDSCO’s fully digital platform.
As of 2026, all Class A (measuring/sterile), B, C, and D devices mandate this license for import—non-measuring/non-sterile Class A devices often register instantly but still need compliance. The process aligns with global standards like ISO 13485, and many U.S./EU-approved devices benefit from faster reviews via recognized certifications.
The approval journey starts with risk classification per CDSCO lists (A low-risk to D high-risk). Higher classes demand more rigorous data, but the core import license pathway remains consistent.
Step-by-Step Process for Form MD-14 Approval in 2026
- Appoint an Authorized Indian Agent (AIA) Foreign entities appoint an Indian entity (importer/distributor) with a wholesale drug license or registration certificate. The AIA acts as the legal importer, handles submissions, queries, and post-approval compliance. Power of Attorney (PoA) must be apostilled or notarized.
- Prepare Documentation Compile the dossier per Fourth Schedule of MDR-2017, including:
- Device Master File (DMF) – design, specs, intended use, labeling.
- Plant Master File (PMF) – manufacturing site details, quality systems.
- Quality certificates (ISO 13485, CE/FDA equivalents if applicable).
- Free Sale Certificate/Marketing Authorization from country of origin or GHTF members (USA, EU, etc.).
- Declaration of Conformity.
- Labeling, IFU, and clinical/performance data for higher classes.
- Register on SUGAM Portal & Submit Form MD-14 AIA creates/logs into SUGAM (cdscoonline.gov.in), generates Form MD-14, uploads documents, pays fees, and submits. Application includes device details, variants, and grouping justification.
- CDSCO Review & Queries CDSCO evaluates for completeness, safety, and efficacy. Queries may arise (respond within timelines). Audits or additional data possible for Class C/D.
- Grant of Import License (Form MD-15) Upon approval, MD-15 issues—perpetual validity (no expiry, but retention fee every 5 years). License lists devices by site.
Key Documents Checklist for Fresh MD-14 Application
| Document Category | Specific Requirements | Mandatory for All Classes? | Notes for 2026 |
|---|---|---|---|
| Covering Letter & Form MD-14 | Application details, device list | Yes | Digital only via SUGAM |
| Power of Attorney | Apostilled/notarized PoA + undertaking from AIA | Yes | From overseas manufacturer |
| AIA License | Wholesale/Manufacturing license copy | Yes | Form 20/21B or MD-42 |
| Regulatory Certificates | Free Sale Cert/Marketing Auth from origin + GHTF countries (USA/EU/etc.) | Yes | Notarized copies |
| Quality Management | ISO 13485 cert, CE/FDA equivalents, Declaration of Conformity | Yes | Duly notarized |
| Master Files | Plant Master File (Appendix I), Device Master File (Appendix II) | Yes | Full for new; updates for additions |
| Fees & Challan | Per Second Schedule (varies by class/devices) | Yes | Online payment |
Timelines: 6–12 months typical (faster for low-risk with strong dossiers; queries extend). Fees start low for Class A but rise for higher classes/multiple devices.
Comparison: Import License Pathways by Device Class (2026)
| Class | Risk Level | Key Requirements | Typical Timeline | License Validity |
|---|---|---|---|---|
| A (non-meas/non-sterile) | Low | Basic registration; minimal dossier | Weeks–months | Perpetual |
| A (meas/sterile), B | Low-Moderate | Full MD-14 + DMF/PMF | 6–9 months | Perpetual |
| C | Moderate-High | Clinical/performance data + audits possible | 9–18 months | Perpetual |
| D | High | Extensive clinicals, site audits likely | 12–24+ months | Perpetual |
Experts note 2026 sees streamlined digital processes on SUGAM, with perpetual licenses reducing renewal burdens (pay retention every 5 years). Public feedback praises transparency but highlights query delays for incomplete dossiers.
For U.S. exporters, this opens doors amid US-India medical devices trade growth—tariff reductions and PLI incentives boost exports. In high-tech ZIPs like 94105 (San Francisco), firms gain from faster approvals via FDA equivalence. Border areas (e.g., ZIP 79901 El Paso) benefit from quicker supply of affordable devices.
User intent? Importers seek clear steps to avoid rejections—tip: Engage consultants early for dossier prep and query handling, cutting timelines by months.
Import license medical devices India via CDSCO Form MD-14 and MD-15 import license remains streamlined on the SUGAM portal medical devices under CDSCO medical device import 2026 rules. With perpetual validity and digital efficiency, prepared applicants secure market access swiftly in this high-growth sector.